Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) Short Interest Update

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) was the target of a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 226 shares, an increase of 465.0% from the June 15th total of 40 shares. Based on an average daily volume of 1,898 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s stock are short sold.

Orion OYJ Price Performance

ORINY stock remained flat at $38.86 during trading on Friday. 132 shares of the company’s stock were exchanged, compared to its average volume of 519. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.77 and a quick ratio of 1.13. The stock has a market cap of $10.97 billion, a P/E ratio of 17.82 and a beta of 0.08. Orion OYJ has a twelve month low of $30.89 and a twelve month high of $42.75. The stock has a 50 day moving average price of $38.36 and a 200 day moving average price of $38.60.

Orion OYJ (OTCMKTS:ORINY) last posted its earnings results on Thursday, April 23rd. The company reported $0.37 EPS for the quarter. The firm had revenue of $488.80 million for the quarter. Orion OYJ had a net margin of 27.14% and a return on equity of 49.17%.

About Orion OYJ

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.